BobuA.18902.a
Pts system, fructose-specific iiabc component (BB_0408)
CENTER ID:
BobuA.18902.a
ORGANISM:
Borrelia burgdorferi B31
ASSOCIATED DISEASE:
Lyme disease
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
I
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
BobuA.18902.a.B2.GE38791
PTS EIIB type-2 subunit
info
161
265
BobuA.18902.a.B2.GE38791
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
BobuA.18902.a.B2.PS02426
PTS EIIB type-2 subunit
info
161
265
PS02426
BobuA.18902.a.B2.PS38122
PTS EIIB type-2 subunit
info
161
265
PS38122
Structures
5DLE
DEPOSITED: 9/4/2015
DETERMINATION: XRay
CLONE: BobuA.18902.a.B2.GE38791
PROTEIN: BobuA.18902.a.B2.PS02426
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MFFNFLKKDL VFVLPEVNSK EDVIDFLIEK INDKGYIDNK KEFLQGILDR EKIGDTSWEN GVAIPHFIGD VVKTSFISLL YIKGSGVKWS EENPPVNLIF LICMSKKQQG NEHLKAIAFI AKLFEDDAFQ NALRGFVTTD DIYYYIENVQ RKAKEEVFGA TKAEKIVAVT ACPVGVAHTY IAAKKIENEA KKQGYSIRVE TQGSIGIENA LTEEEIKNAS VVILAVDKDI DEKRFEGKRV YKVSTVKAIN NTENIIKESF NAPVFKSKDS GTNSDTKASV ATGKGSFYKY LMSGVSPMIP VVASGGILIA LSIAFVGIGP DGPNFAEHPF YKQIADIGSI AFGMMLPVLA GFIAMAIADK PGLTPGLVGG VMSGNVKAGF LGAIFAGFLA GYVARFLARR SVPEWLRPVM PIFVIPLIST IIVGFFMLYF GVYIGKFMGV LESGLKSLQS NSETFGVLGK IFLGLVLGSM ITVDMGGPFN KVAFLFGVGL IPQVPEIMGM VAAAIPVPPM AMGLATFLAP KLFENEEKES GKIAFLISFI GISEGAIPFA ASDPGRVIPS IVVGGAVSSI IAAFLGVANH APHGGPIVLP VIDNKFGFII AIAVGVAVAT ALVIFLKSLK LKESE
NT Sequence
atgtttttta attttttgaa aaaagatctt gtatttgttt tgccagaagt aaattcaaaa gaagatgtaa ttgatttttt aattgaaaaa atcaatgata agggatatat agataataaa aaagagtttc ttcaaggaat tcttgataga gaaaagatag gtgacacttc ttgggaaaat ggggttgcaa ttcctcattt tataggagat gttgttaaga ctagttttat ttcattgctt tacattaaag gttctggggt taagtggtct gaagaaaacc cccctgttaa tttaatattt ttgatttgta tgtcaaaaaa acaacaaggt aatgaacacc ttaaggcgat tgcttttata gctaaactat ttgaagatga tgcttttcaa aatgctttac gcgggtttgt tactactgat gacatttatt attatattga aaatgttcaa agaaaggcta aagaagaggt ttttggagct acaaaagcag aaaaaatagt ggccgtaact gcttgtcctg ttggagttgc tcatacgtat attgcagcta agaaaattga aaatgaagct aaaaagcagg gttatagcat tagagtagaa actcaaggat ctattggtat tgaaaatgcc ttaacagaag aggaaattaa gaatgcgtcc gttgtaatac ttgctgttga taaggatatt gatgaaaaga gatttgaagg taagagagtt tataaagttt caactgtaaa agcgataaac aatacagaaa atattattaa ggaatctttt aatgctccgg tatttaaaag caaagactcc ggtactaata gtgatactaa agcttcggtt gcaacaggca aaggtagttt ttataaatat ttaatgagtg gggtatctcc aatgattcct gttgttgcaa gtggaggaat tttaattgct cttagcattg cttttgttgg gattggacct gatgggccta attttgctga gcatccattt tataagcaga ttgcagatat tggttctata gcttttggga tgatgttgcc cgtgcttgct ggttttattg caatggcaat tgctgataag cctggtctta cccccggtct tgttggtgga gtaatgtctg ggaatgtaaa agcaggtttc ttgggcgcaa tatttgcggg ctttcttgca ggttatgttg caaggttttt agcaagaaga tctgttcctg agtggttaag acctgtaatg cctatatttg taattccgct aataagcacc attattgtcg gcttttttat gctgtatttt ggtgtttata ttggaaaatt tatgggggtg cttgagagtg ggcttaaatc tttacagagt aattcggaaa cttttggcgt gttgggtaaa attttcttag gcttagtact aggttcaatg attactgttg atatgggcgg accttttaat aaagtggcat ttctttttgg tgtagggcta attcctcaag tgccagaaat aatgggaatg gtagcagcag caattcctgt tcctcctatg gctatggggc ttgcaacctt tttagcacct aaattgtttg aaaatgaaga aaaagaatct ggtaaaatag cctttttaat ttcatttatt ggtattagcg aaggagctat tccttttgct gctagtgatc ccggacgggt aatcccttcg atagtggtag ggggagctgt atcaagcatt attgccgctt ttttaggcgt tgctaatcat gctccacacg gaggaccaat agtacttcct gttattgata ataaatttgg gtttattatt gcaattgctg ttggagttgc ggttgcaaca gctttggtaa tttttttgaa atctttaaaa ttaaaggaat ctgaatga
Details for BobuA.18902.a.B2.GE38791
HARVESTED ON:
1/22/2015
SEQUENCED ON:
1/15/2015
EXPECTED MW:
13kDa
OBSERVED MW:
13kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Too many to count (100+)
TOTAL EXPRESSION LEVEL:
Low Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
100
PERCENT COVERAGE:
100
Details for BobuA.18902.a.B2.PS02426
PURIFICATION DATe:
6/11/2015
CONCENTRATION:
44.6mg/ml
OBSERVED MW:
14kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
3
VIAL VOLUME:
110µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
100
Details for BobuA.18902.a.B2.PS38122
PURIFICATION DATe:
11/17/2016
CONCENTRATION:
46.8mg/ml
OBSERVED MW:
14kDa
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
SEC Buffer
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
7
VIAL VOLUME:
200µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
100